Home Newsfeeds Yield10 Bioscience: Q4 Earnings Insights

Earnings

Yield10 Bioscience: Q4 Earnings Insights

Yield10 Bioscience (NASDAQ:YTEN) reported its Q4 earnings results on Monday, April 1, 2024 at 04:01 PM. Here’s what…

byBenzinga Insights

April 1, 2024

1 minute read

Yield10 Bioscience (NASDAQ:YTEN) reported its Q4 earnings results on Monday, April 1, 2024 at 04:01 PM.

Here’s what investors need to know about the announcement.

Earnings

Yield10 Bioscience beat estimated earnings by 10.0%, reporting an EPS of $-0.27 versus an estimate of $-0.3.

Revenue was down $87 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 15.0% drop in the share price the next day.

Here’s a look at Yield10 Bioscience’s past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.39	-0.54	-0.63	-0.60
EPS Actual	-0.41	-0.64	-0.76	-0.67
Revenue Estimate	70K	30K	70K	120K
Revenue Actual	0	0	60K	87K

To track all earnings releases for Yield10 Bioscience visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Why Paramount Global Shares Are Plunging Today

By Anusuya Lahiri

May 4, 9:20 AM

Paramount Global (NASDAQ: PARA) reported a first-quarter FY23 revenue decline of 1% year-on-year to $7.265 billion, missing the consensus of $7.420 billion. Total global viewing hours across Paramount+ and Pluto TV increased by over 50% Y/Y and over 20% Q/Q.

PARA

Earnings

Entravision Comms Earnings Preview

By Benzinga Insights

November 1, 1:01 PM

Entravision Comms (NYSE:EVC) is set to give its latest quarterly earnings report on Thursday, 2023-11-02. Here’s what investors…

EVC

Oracle Stock Is Moving Higher Wednesday: What’s Going On?

By Adam Eckert

June 12, 8:44 AM

Oracle reported fourth-quarter revenue of $14.3 billion, missing the consensus estimate of $14.554 billion, according to Benzinga Pro. Oracle reported fourth-quarter adjusted earnings of $1.63 per share, missing average analyst estimates of $1.65 per share.

GOOG

Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram’s Q4 Revenue And Adjusted EBITDA

By Jelena Martinovic

December 19, 12:41 PM

Canadian cannabis producer Organigram Holdings reported an 11% year-over-year increase in net revenue for the fourth quarter, reaching C$A161.6 million ($121 million). The company credited the growth to its focus on innovative products that meet consumer demand for convenience, such as pre-rolls and edibles. The increase in revenue contributed to a 71% rise in adjusted EBITDA to nearly CA$6m for the quarter, compared with the same period in 2022. Organigram's adjusted gross margin was CA$40.2m, up 20% on 2022. The company also reported a net loss of CA$248.6m, compared with CA$14.3m in 2022, due to impairments on property, plant and equipment, intangibles and goodwill. Organigram said it expects improved margins in future as efficiency gains from facility upgrades and expansion into higher-margin categories such as craft flower and vapes bear fruit.

OGI